These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4318424)
21. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)). Schulz EJ Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819 [No Abstract] [Full Text] [Related]
22. Possible incompatibility of dapsone with clofazimine in the treatment of patients with erythema nodosum leprosum. Imkamp FM; Anderson R; Gatner EM Lepr Rev; 1982 Jun; 53(2):148-9. PubMed ID: 7098753 [No Abstract] [Full Text] [Related]
23. ENL in borderline leprosy. Karat AB; Job CK; Karat S Int J Lepr Other Mycobact Dis; 1967; 35(3):402-3. PubMed ID: 5630364 [No Abstract] [Full Text] [Related]
24. THE HISTOPATHOLOGY AND HISTOCHEMISTRY OF ERYTHEMA NODOSUM LEPROSUM. MABALAY MC; HELWIG EB; TOLENTINO JG; BINFORD CH Int J Lepr; 1965; 33():28-49. PubMed ID: 14282354 [No Abstract] [Full Text] [Related]
25. The treatment of corticosteroid-dependent lepromatous patients in persistent Erythema nodosum leprosum with clofazimine. Imkamp FM Lepr Rev; 1973 Sep; 44(3):127-30. PubMed ID: 4788877 [No Abstract] [Full Text] [Related]
26. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy. Hastings RC; Trautman JR; Mansfield RE Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403 [No Abstract] [Full Text] [Related]
33. Erythema nodosum leprosum in the absence of chemotherapy. Godal T; Pearson JM; Ross WF Lancet; 1973 Apr; 1(7808):880. PubMed ID: 4123420 [No Abstract] [Full Text] [Related]
34. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up. Magora A; Sheskin J; Sagher F; Gonen B Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246 [No Abstract] [Full Text] [Related]
35. [Clinical studies in the use of cortisone and corticotropin in the reactive episodes of leprosy]. SHUTTLEWORTH JS Int J Lepr; 1956; 24(2):129-37. PubMed ID: 13376140 [No Abstract] [Full Text] [Related]
37. The effect of stopping dapsone treatment for two months and then restarting it in full dosage in patients with moderately severe erythema nodosum leprosum. Pearson JM; Helmy HS Lepr Rev; 1973 Jun; 44(2):75-82. PubMed ID: 4733886 [No Abstract] [Full Text] [Related]
38. Erythema nodosum leprosum necroticans in a child--an unusual manifestation. Pandhi D; Mehta S; Agrawal S; Singal A Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655 [TBL] [Abstract][Full Text] [Related]
39. Jaundice occurring as a complication of erythema nodosum leprosum (a report of two cases). Kumar B; Singh S; Kaur S Lepr India; 1980 Oct; 52(4):586-90. PubMed ID: 7464064 [TBL] [Abstract][Full Text] [Related]
40. A survey of the drugs with activity against M. leprae in mice. Shepard CC Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]